Paul Peter Tak, CEO, Director at Candel Therapeutics, holds 294.79K shares in Candel Therapeutics (Ticker: CADL). Most recently, Paul Peter Tak Sold $48,847 shares of Candel Therapeutics on Dec 03, 2024 for an estimated value of 222.25K.
What is the percentage of profitable transactions made by Paul Peter Tak?
The percentage of profitable transactions made by Paul Peter Tak is 40%.
What is the average return per transaction made by Paul Peter Tak?
The average return per transaction made by Paul Peter Tak is -17.80%.
What stocks does Paul Peter Tak hold?
Paul Peter Tak holds: CADL stocks.
What was Paul Peter Tak’s latest transaction?
Paul Peter Tak latest transaction was an Informative Sell of $222.25K.
What was Paul Peter Tak's most profitable transaction?
Paul Peter Tak’s most profitable transaction was an Informative Sell of CADL stock on July 15, 2024. The return on the trade was 22.30%.
What is Paul Peter Tak's role in Candel Therapeutics?
Paul Peter Tak's role in Candel Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.